.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstractvortrag
VS-21-9

Upregulation of check-point ligand PD-L1 in patients with PNH explained by proximal complement activation

Appointment

Date: 23/09/2022

Time: 09:50 – 10:00

Talk time: 6 Min.

Discussion time: 4 Min.

Location / Stream:

Gustav Mahler 3.2

Session

Immunhämatologie

Topics

7. Immunhämatologie und Immunologische Grundlagen
9. Hämotherapie

Authors

Dr. med. Markus Anliker (Innsbruck / AT), Daniela Drees (Ulm / DE), Lorin Loacker (Innsbruck / AT), Andrea Griesmacher (Innsbruck / AT), Primar Univ. Doz. Dr. Harald Schennach (Innsbruck / AT), Paul Hörtnagl (Innsbruck / AT), Arthur Dobler (Ulm / DE; Innsbruck / AT), Astrid Marx-Hofmann (Ulm / DE), Dr. med. Sixten Körper (Ulm / DE), Britta Höchsmann (Ulm / DE), Prof. Hubert Schrezenmeier (Ulm / DE), Dr. Christian Schmidt (Ulm / DE)